SRD5A2L2 Antibody (601CT22.4.3): sc-517363
- SRD5A2L2 Antibody (601CT22.4.3) is a mouse monoclonal IgG1 SRD5A2L2 antibody provided at 50 µl ascites
- raised against a synthetic peptide corresponding to amino acids 325-354 in the C-terminal region of SRD5A2L2 of human origin
- recommended for detection of SRD5A2L2 of human origin by WB
- At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for SRD5A2L2 Antibody (601CT22.4.3). This work is in progress.
QUICK LINKS
SEE ALSO...
SRD5A2L2 Antibody (601CT22.4.3) is a mouse monoclonal IgG1 antibody that detects SRD5A2L2 protein of human origin by western blotting (WB). Anti-SRD5A2L2 antibody (601CT22.4.3) is available as a non-conjugated format. SRD5A2L2, also known as steroid 5-alpha-reductase 2-like 2 protein, TERL, GPSN2L, or trans-2,3-enoyl-CoA reductase-like, is a 363 amino acid multi-pass membrane protein that plays a crucial role in lipid metabolism and cellular signaling pathways. SRD5A2L2 functions in steroid hormone reduction, influencing various physiological processes, including development and reproduction. Located within the cell membrane, SRD5A2L2 interacts with lipid substrates and other membrane-associated proteins, facilitating enzymatic activity. SRD5A2L2 is encoded by a gene on human chromosome 4, a region significant for genetic diversity and association with various genetic disorders, including Huntington′s disease and polycystic kidney disease. SRD5A2L2 (601CT22.4.3) antibody specifically targets this protein, making this reagent valuable for researchers studying its role in health and disease.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
SRD5A2L2 Antibody (601CT22.4.3) References:
- Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | Hillier, LW., et al. 2005. Nature. 434: 724-31. PMID: 15815621
- Selective neuronal degeneration in Huntington's disease. | Cowan, CM. and Raymond, LA. 2006. Curr Top Dev Biol. 75: 25-71. PMID: 16984809
- Growth hormone analysis and treatment in Ellis-van Creveld syndrome. | Versteegh, FG., et al. 2007. Am J Med Genet A. 143A: 2113-21. PMID: 17702014
- Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature. | Doherty, ES., et al. 2007. Am J Med Genet A. 143A: 3204-15. PMID: 18000976
- Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice. | Stack, EC., et al. 2007. J Neurosci. 27: 12908-15. PMID: 18032664
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SRD5A2L2 Antibody (601CT22.4.3) | sc-517363 | 50 µl ascites | $322.00 |